A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study.
about
HSP90 inhibitor AUY922 can reverse Fulvestrant induced feedback reaction in human breast cancer cellsTargeting cancer cell mitochondria as a therapeutic approach: recent updates.Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 Prostate Cancer CellsIn vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell LinesHyponatremia and V2 vasopressin receptor upregulation: a result of HSP90 inhibition.Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer.HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome.Inhibition of heat shock protein 90 exerts an antitumour effect in angiosarcoma: involvement of the vascular endothelial growth factor signalling pathway.
P2860
Q33823200-B59F5C11-7889-4B94-8FEB-C6520CBC31D6Q38668524-769F2AB9-60E1-4A01-B2DA-F1B9728B9FD4Q38759678-181A4395-2AEA-4687-8EE8-7597F08EE660Q41395890-23B5108C-8E87-4879-9A1C-562562B6C2D8Q42362272-14A72ACE-CCB3-4923-A0E0-A0FB0FB189E8Q47222377-D05E452F-5D34-43FB-A0EF-7FC197C7FCC6Q47811299-1D4B32B6-B5BC-4D09-9A4C-A8CEA244072FQ48292976-E2E1B01F-CEE5-4017-99B4-270A666C7F4FQ51197604-079CB779-1EAE-43D9-B6F4-73435DC5E1D5
P2860
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A phase II trial of ganetespib ...... ials consortium (PCCTC) study.
@en
A phase II trial of ganetespib ...... ials consortium (PCCTC) study.
@nl
type
label
A phase II trial of ganetespib ...... ials consortium (PCCTC) study.
@en
A phase II trial of ganetespib ...... ials consortium (PCCTC) study.
@nl
prefLabel
A phase II trial of ganetespib ...... ials consortium (PCCTC) study.
@en
A phase II trial of ganetespib ...... ials consortium (PCCTC) study.
@nl
P2093
P2860
P1476
A phase II trial of ganetespib ...... rials consortium (PCCTC) study
@en
P2093
Daryn Smith
Elisabeth I Heath
Emmanuel S Antonarakis
Lance K Heilbrun
Manish K Thakur
Mark Stein
Shijie Sheng
Sijana H Dzinic
Stacy Freeman
P2860
P2888
P304
P356
10.1007/S10637-015-0307-6
P50
P577
2015-11-18T00:00:00Z